Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2015, Article ID 131508, 7 pages
Clinical Study

Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson’s Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study

1Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain
2Hospital Santa Maria de Lleida, 25007 Lleida, Spain
3Hospital de Mataró, 08302 Barcelona, Spain
4Hospital del Mar, 08003 Barcelona, Spain
5Hospital de Granollers, 08401 Barcelona, Spain
6Hospital Son Espases, 07120 Barcelona, Spain
7Corporació Sanitària Parc Taulí, 08208 Barcelona, Spain
8Hospital de Martorell, 08760 Martorell, Spain
9Hospital General de Catalunya, 08915 Barcelona, Spain
10Hospital de Figueres, 17600 Girona, Spain
11Hospital Germans Trias i Pujol, 07014 Barcelona, Spain

Received 17 November 2014; Revised 3 February 2015; Accepted 5 February 2015

Academic Editor: Antonio Pisani

Copyright © 2015 Javier Pagonabarraga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

The Supplementary Material includes the newly designed “Parkinson’s Disease – Sleep Fragmentation Questionnaire (PD-SFQ)”. This questionnaire assesses the presence of sleep symptoms that have an influence on sleep fragmentation, such as the number of awakenings per night, nocturia, restless legs-like symptoms, and nocturnal akinesia .

  1. Supplementary Material